Previous studies in humans demonstrate that fkbp5 levels are highly responsive to chronic stress and stress-related diseases (e.g. bipolar disorder; depression in AD [58]), implying that fkbp5 expression is a sensitive marker of glucocorticoid signalling. This evidence concerns the gene FKBP5 and major depressive disorder.